000			02054 a2200565 4500
005			20250513164151.0
264		0	_c19990222
008			199902s 0 0 eng d
022			_a0360-3016
024	7		_a10.1016/s0360-3016(98)00370-8 _2doi
040			_aNLM _beng _cNLM
100	1		_aKoukourakis, M I
245	0	0	_aConcurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation. _h[electronic resource]
260			_bInternational journal of radiation oncology, biology, physics _cJan 1999
300			_a107-14 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents, Phytogenic _xadministration & dosage
650	0	4	_aBrain Neoplasms _ximmunology
650	0	4	_aCarcinoma, Non-Small-Cell Lung _ximmunology
650	0	4	_aCombined Modality Therapy
650	0	4	_aDocetaxel
650	0	4	_aDose Fractionation, Radiation
650	0	4	_aDrug Administration Schedule
650	0	4	_aFeasibility Studies
650	0	4	_aFemale
650	0	4	_aGlioblastoma _ximmunology
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _ximmunology
650	0	4	_aLymphocytes _xdrug effects
650	0	4	_aLymphopenia _xetiology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasms _ximmunology
650	0	4	_aNeutropenia _xetiology
650	0	4	_aPaclitaxel _xadministration & dosage
650	0	4	_aPelvic Neoplasms _ximmunology
650	0	4	_aRadiation-Sensitizing Agents _xadministration & dosage
650	0	4	_aRadiotherapy _xadverse effects
650	0	4	_aSurvival Analysis
650	0	4	_aTaxoids
650	0	4	_aTreatment Outcome
700	1		_aGiatromanolaki, A
700	1		_aSchiza, S
700	1		_aKakolyris, S
700	1		_aGeorgoulias, V
773	0		_tInternational journal of radiation oncology, biology, physics _gvol. 43 _gno. 1 _gp. 107-14
856	4	0	_uhttps://doi.org/10.1016/s0360-3016(98)00370-8 _zAvailable from publisher's website
999			_c9950924 _d9950924